The eighth annual Digital Biomarkers in Clinical Trials Summit, hosted in partnership with Roche in Basel, stands as the unique global forum dedicated to advancing pharmaceutical clinical trials. This event focuses on leveraging new opportunities to enhance data collection and elevate the patient experience. It also explores how emerging digital health tools (DHT) can effectively complement existing biomarker strategies.
Scheduled for June 25, 2025, at Roche Headquarters in Basel, the summit will gather over 40 speakers and advisors alongside more than 350 senior-level executives from pharma, clinical trials, technology, and digital health sectors. Attendees will have the opportunity to learn, network, and develop strategies for utilizing mobile-enabled technologies, wearables, and decentralized clinical trial capabilities to improve biomarker strategies, optimize patient experience, and collect superior data. Global experts will converge to discuss the forefront of wearable sensor technology, data management, analytics, connected devices, decentralized clinical trials, and biomarker strategies in clinical research, making this an essential gathering for professionals in R&D, sales & marketing, IT, data management, patient recruitment, retention, adherence, AI, digital health, digital biomarkers, decentralized trials, quantitative, or translational medicine.
